BioAge Labs, Inc. (BIOA)

Price$9.59Cached quote
BIOANasdaq
Loading local price history

Financial charts

Net income

Total cash / debt

CashTotal debt

Financial statements

4 annual periodsNewest to oldest
2025202420232022
Revenue$9.0M$0$0$0
Research & development$74.0M$59.0M$33.9M$30.5M
Operating expenses$101.8M$78.2M$48.4M$40.0M
Operating income−$92.8M−$78.2M−$48.4M−$40.0M
Operating margin−1,031.46%———
EBITDA−$92.6M−$78.0M−$48.2M−$39.4M
EBITDA margin−1,029.24%———
Net income−$80.6M−$71.1M−$63.9M−$39.7M
Net profit margin−896.11%———
Basic EPSper basic share-$2.24-$6.63-$38.17-$23.76
Diluted EPSper diluted share-$2.24-$6.63-$38.17-$23.76

Owners

Reported shareholders

Reference date Jun 30, 2026
a16z Capital Management, L.L.C. · 7.06% of listed sharesPande Vijay Satyanand · ≈7.06% of listed sharesBlackRock, Inc. · 6.22% of listed sharesCormorant Asset Management, LP · 5.22% of listed sharesHEALY JAMES · ≈5.04% of listed sharesSofinnova Investments, Inc. · 5.01% of listed sharesJupiter Topco LLC · 4.68% of listed sharesOctagon Capital Advisors LP · 3.82% of listed sharesENRIGHT PATRICK G · ≈3.74% of listed sharesRA CAPITAL MANAGEMENT, L.P. · 3.65% of listed sharesMPM BIOIMPACT LLC · 3.64% of listed sharesVANGUARD CAPITAL MANAGEMENT LLC · 3.37% of listed sharesPolar Capital Holdings Plc · 2.34% of listed sharesBRAIDWELL LP · 2.26% of listed sharesSTATE STREET CORP · 2.23% of listed sharesGEODE CAPITAL MANAGEMENT, LLC · 2.19% of listed sharesFortney Kristen · ≈2.13% of listed sharesSands Capital Alternatives, LLC · 1.72% of listed sharesORBIMED ADVISORS LLC · 1.64% of listed sharesD. E. Shaw & Co., Inc. · 1.62% of listed shares
7.06%of listed shares
a16z Capital Management, L.L.C.3.23M shares · Jun 30, 2026
View holders
Top 20 reported holders of BIOA
Holder% owned
a16z Capital Management, L.L.C.
7.06%3.23M shares
Pande Vijay Satyanand
≈7.06%3.23M shares
BlackRock, Inc.
6.22%2.85M shares
Cormorant Asset Management, LP
5.22%2.39M shares
HEALY JAMES
≈5.04%2.3M shares
Sofinnova Investments, Inc.
5.01%2.29M shares
Jupiter Topco LLC
4.68%2.14M shares
Octagon Capital Advisors LP
3.82%1.75M shares
ENRIGHT PATRICK G
≈3.74%1.71M shares
RA CAPITAL MANAGEMENT, L.P.
3.65%1.67M shares
MPM BIOIMPACT LLC
3.64%1.67M shares
VANGUARD CAPITAL MANAGEMENT LLC
3.37%1.54M shares
Polar Capital Holdings Plc
2.34%1.07M shares
BRAIDWELL LP
2.26%1.03M shares
STATE STREET CORP
2.23%1.02M shares
GEODE CAPITAL MANAGEMENT, LLC
2.19%1M shares
Fortney Kristen
≈2.13%976.95K shares
Sands Capital Alternatives, LLC
1.72%786.35K shares
ORBIMED ADVISORS LLC
1.64%752.15K shares
D. E. Shaw & Co., Inc.
1.62%742.76K shares

Percentages use 45.78M shares of this listed class outstanding on Jun 30, 2026. ≈ compares the latest reported holding with a share total from a different date; it is not a confirmed current stake.

Gray completes the 100% scale. Reported positions may overlap; holders have different reporting dates.

Source: SEC Form 13F ↗Updated Sep 29, 2026 · Quarterly data

Insider buys & sells

Jul 1, 2024–Jun 30, 2026
Buys13$47.93M disclosed value
Sells (SEC code S)11$6.22M disclosed value
24 recent transactions
TransactionInsiderTypeSharesPriceValueOwned after
Apr 1, 2026Form 4 · 10b5-1RUBIN PAUL DChief Medical OfficerSellCommon Stock8.8K$17.81$157.1K0
Mar 2, 2026Form 4 · 10b5-1RUBIN PAUL DChief Medical OfficerSellCommon Stock7.4K$20.30$150.9K0
Feb 2, 2026Form 4 · 10b5-1RUBIN PAUL DChief Medical OfficerSellCommon Stock7.4K$18.75$139.4K0
Jan 13, 2026Form 4 · 10b5-1Fortney KristenChief Executive OfficerSellCommon Stock233.1K$18.12$4.22M976.9K
Jan 13, 2026Form 4 · 10b5-1GOLDSTEIN DOV A MDChief Financial OfficerSellCommon Stock1.9K$21.08$40.5K22.4K

Community posts

It’s quiet here.

No posts about BIOA yet. Start the conversation.

Write the first post